SCHEMBL4063387

SCHEMBL4063387

Cc1cc(Cl)ccc1Oc1ccc(NC(=O)c2ccc3ccccc3c2)cn1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.53
RAB9A P51151 5/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
TDP1 Q9NUW8 1/20 0.53
GRM8 O00222 1/20 0.52
GRM7 Q14831 1/20 0.52
GRM4 Q14833 1/20 0.52
DGAT1 O75907 3/20 0.51
CASP3 P42574 3/20 0.51
SENP7 Q9BQF6 3/20 0.51
NQO2 P16083 1/20 0.51
PARG Q86W56 1/20 0.50
F10 P00742 1/20 0.49
KCNQ3 O43525 1/20 0.48
KCNQ2 O43526 1/20 0.48
KCNE1 P15382 1/20 0.48
KCNQ1 P51787 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP6 Q9GZR1 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4060811 0.89 GRM8 (0.56) NPC1RAB9AMEN1KMT2AGRM8
SCHEMBL4069994 0.86 NPC1 (0.54) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL4064115 0.85 GRM8 (0.52) NPC1RAB9AMEN1KMT2AGRM8
SCHEMBL4062244 0.83 PNLIP (0.60) NPC1RAB9AMEN1KMT2ATDP1
SCHEMBL4067290 0.83 GRM8 (0.53) NPC1RAB9AMEN1KMT2AGRM8
SCHEMBL4065169 0.83 RAB9A (0.57) NPC1RAB9AMEN1KMT2AGRM8
SCHEMBL4229637 0.82 HTR2C (0.67) HTR2C
SCHEMBL4065181 0.82 GRM4 (0.57) MEN1KMT2AGRM8GRM7GRM4
SCHEMBL4058614 0.82 GRM8 (0.53) GRM8GRM7GRM4HTR2C
SCHEMBL4240750 0.82 PNLIP (0.56) GRM8GRM7GRM4PARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1028945-B9 SUBSTITUTED PYRIDINE COMPOUNDS AS ANTI-INFLAMMATORY AGENTS AMGEN INC (US) 2009-02-18 EP disclosed
EP-1028945-B1 SUBSTITUTED PYRIDINE COMPOUNDS AS ANTI-INFLAMMATORY AGENTS AMGEN INC (US) 2007-07-11 EP disclosed